IRIS
DI BENEDETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.601
EU - Europa 2.408
AS - Asia 2.252
SA - Sud America 212
Continente sconosciuto - Info sul continente non disponibili 186
AF - Africa 37
OC - Oceania 6
Totale 9.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.516
SG - Singapore 973
IE - Irlanda 535
IT - Italia 509
CN - Cina 499
RU - Federazione Russa 440
SE - Svezia 225
HK - Hong Kong 212
VN - Vietnam 209
TR - Turchia 200
BR - Brasile 184
DE - Germania 174
UA - Ucraina 131
GB - Regno Unito 128
FR - Francia 84
FI - Finlandia 61
CA - Canada 52
IN - India 49
NL - Olanda 32
BE - Belgio 28
JP - Giappone 21
BD - Bangladesh 17
MX - Messico 13
ID - Indonesia 11
PL - Polonia 11
ZA - Sudafrica 11
ES - Italia 10
EC - Ecuador 9
IQ - Iraq 9
AR - Argentina 8
CZ - Repubblica Ceca 8
KR - Corea 6
DZ - Algeria 5
JM - Giamaica 5
LT - Lituania 5
SA - Arabia Saudita 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
AU - Australia 4
LB - Libano 4
PK - Pakistan 4
UZ - Uzbekistan 4
CH - Svizzera 3
CO - Colombia 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
MA - Marocco 3
MK - Macedonia 3
MY - Malesia 3
PH - Filippine 3
BB - Barbados 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SC - Seychelles 1
TH - Thailandia 1
UY - Uruguay 1
Totale 9.521
Salva come PNG Salva come JPEG
Città #
Chandler 603
Dublin 535
Jacksonville 533
Singapore 523
San Jose 489
Ashburn 376
Council Bluffs 222
Dallas 222
Hong Kong 208
Santa Clara 187
Boardman 148
Izmir 137
New York 123
The Dalles 104
Beijing 100
Ann Arbor 95
L'aquila 82
Nanjing 80
Lawrence 75
Milan 75
Moscow 75
Princeton 75
Los Angeles 68
Ho Chi Minh City 67
Wilmington 64
San Mateo 44
Dearborn 42
Hanoi 41
Woodbridge 35
Nanchang 31
Rome 31
Amsterdam 30
Columbus 26
Dong Ket 26
L’Aquila 26
Verona 26
Lauterbourg 25
Brussels 24
Munich 24
São Paulo 24
Helsinki 22
Hefei 21
Naples 21
Shanghai 21
Tokyo 21
Orem 18
Seattle 17
Atlanta 16
Kunming 16
Montreal 16
Mountain View 16
Shenyang 16
Chicago 15
Houston 15
Jiaxing 14
Chennai 13
Des Moines 12
Haiphong 12
Frankfurt am Main 11
Hebei 11
Las Vegas 11
San Francisco 11
Tianjin 11
Zhengzhou 11
Johannesburg 10
Miano 10
Phoenix 10
Pune 10
Stockholm 10
Warsaw 10
Changsha 9
Guangzhou 9
Ningbo 9
Washington 9
Florence 8
Genoa 8
Grafing 8
Jinan 8
Norwalk 8
Queens 8
Bologna 7
Jakarta 7
Mumbai 7
Pescara 7
Poplar 7
Brno 6
London 6
Manchester 6
Philadelphia 6
Rio de Janeiro 6
Toronto 6
Afragola 5
Bremen 5
Brooklyn 5
Denver 5
Edinburgh 5
Hangzhou 5
Lanzhou 5
Miami 5
Nuremberg 5
Totale 6.349
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 195
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 170
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 170
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 168
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 167
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 166
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 165
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 164
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 158
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 158
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 156
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 153
Cardiovascular disease in primary sjögren’s syndrome 152
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 152
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 151
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 151
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 149
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 145
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 143
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 143
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 143
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 142
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 140
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 140
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 140
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 138
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 136
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 136
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 132
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 131
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 130
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 130
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 129
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 128
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 128
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 127
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 127
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 127
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 127
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 126
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 124
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 124
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 123
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 122
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 121
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 120
Interstitial lung disease in systemic sclerosis: current and future treatment. 120
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 119
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 119
The Vessels Contribute to Fibrosis in Systemic Sclerosis 118
Cellular players in angiogenesis during the course of systemic sclerosis. 117
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 117
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 117
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 116
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 115
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 113
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 112
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 112
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 111
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 108
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 108
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 106
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 105
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 104
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 101
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives 101
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 100
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 99
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 99
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2 97
Potential of stem cells in the treatment of rheumatic disease 90
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 89
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 86
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor 82
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 77
Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis 77
Totale 9.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.622
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 0 0 38 11 10 4 24 33 38 37 124
2022/20231.580 113 115 29 199 108 166 2 95 675 12 46 20
2023/2024377 60 21 21 29 35 132 9 16 1 15 4 34
2024/20251.492 38 28 146 56 230 121 165 92 330 69 119 98
2025/20262.809 198 260 143 313 282 208 472 92 255 360 186 40
2026/2027887 69 72 257 489 0 0 0 0 0 0 0 0
Totale 9.702